Economic evaluation of Durogesic in moderate to severe, nonmalignant, chronic pain in Germany
Author
Abstract
Suggested Citation
DOI: 10.1007/s10198-006-0376-8
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
References listed on IDEAS
- Dennis G. Fryback & William F. Lawrence & Patricia A. Martin & Ronald Klein & Barbara E.K. Klein, 1997. "Predicting Quality of Well-being Scores from the SF-36," Medical Decision Making, , vol. 17(1), pages 1-9, February.
Citations
Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
Cited by:
- W. Sullivan & M. Hirst & S. Beard & D. Gladwell & F. Fagnani & J. López Bastida & C. Phillips & W. C. N. Dunlop, 2016. "Economic evaluation in chronic pain: a systematic review and de novo flexible economic model," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 17(6), pages 755-770, July.
- Bastian Haß & Juliane Lungershausen & Nadine Hertel & Barbara Poulsen Nautrup & Wioletta Kotowa & Hiltrud Liedgens, 2009. "Cost-effectiveness of strong opioids focussing on the long-term effects of opioid-related fractures: a model approach," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 10(3), pages 309-321, July.
- Stephen Mac & Ryan O’Reilly & Neill K J Adhikari & Robert Fowler & Beate Sander, 2020. "Point-of-care diagnostic tests for influenza in the emergency department: A cost-effectiveness analysis in a high-risk population from a Canadian perspective," PLOS ONE, Public Library of Science, vol. 15(11), pages 1-15, November.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- William F. Lawrence & John A. Fleishman, 2004. "Predicting EuroQoL EQ-5D Preference Scores from the SF-12 Health Survey in a Nationally Representative Sample," Medical Decision Making, , vol. 24(2), pages 160-169, March.
- Brazier, JE & Yang, Y & Tsuchiya, A, 2008. "A review of studies mapping (or cross walking) from non-preference based measures of health to generic preference-based measures," MPRA Paper 29808, University Library of Munich, Germany.
- Jarmo Hahl & Helena Hämäläinen & Tuula Simell & Olli Simell, 2006. "The Effects of Type 1 Diabetes and its Long-Term Complications on Physical and Mental Health Status," PharmacoEconomics, Springer, vol. 24(6), pages 559-569, June.
- Hirsch Ruchlin & Ralph Insinga, 2008. "A Review of Health-Utility Data for Osteoarthritis," PharmacoEconomics, Springer, vol. 26(11), pages 925-935, November.
- Bernie J. O'Brien & Marian Spath & Gordon Blackhouse & J.L. Severens & Paul Dorian & John Brazier, 2003. "A view from the bridge: agreement between the SF‐6D utility algorithm and the Health Utilities Index," Health Economics, John Wiley & Sons, Ltd., vol. 12(11), pages 975-981, November.
- Stavros Petrou & Christine Hockley, 2005. "An investigation into the empirical validity of the EQ‐5D and SF‐6D based on hypothetical preferences in a general population," Health Economics, John Wiley & Sons, Ltd., vol. 14(11), pages 1169-1189, November.
- Maria Orlando Edelen & M. Audrey Burnam & Katherine E. Watkins & José J. Escarce & Haiden Huskamp & Howard H. Goldman & Gary Rachelefsky, 2008. "Obtaining Utility Estimates of the Health Value of Commonly Prescribed Treatments for Asthma and Depression," Medical Decision Making, , vol. 28(5), pages 732-750, September.
- John Brazier & Yaling Yang & Aki Tsuchiya & Donna Rowen, 2010. "A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 11(2), pages 215-225, April.
- Christine McDonough & Anna Tosteson, 2007. "Measuring Preferences for Cost-Utility Analysis," PharmacoEconomics, Springer, vol. 25(2), pages 93-106, February.
- William Hollingworth & Richard A. Deyo & Sean D. Sullivan & Scott S. Emerson & Darryl T. Gray & Jeffrey G. Jarvik, 2002. "The practicality and validity of directly elicited and SF‐36 derived health state preferences in patients with low back pain," Health Economics, John Wiley & Sons, Ltd., vol. 11(1), pages 71-85, January.
- John A. Nyman, 2004. "Should the consumption of survivors be included as a cost in cost–utility analysis?," Health Economics, John Wiley & Sons, Ltd., vol. 13(5), pages 417-427, May.
More about this item
Keywords
Buprenorphine; Chronic pain; Fentanyl; Morphine; Oxycodone;All these keywords.
Statistics
Access and download statisticsCorrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:eujhec:v:7:y:2006:i:4:p:290-296. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.